Category: Disease States

Disease States

Blood-based biomarker tests are revolutionizing Alzheimer's diagnostic testing and management of Alzheimer’s disease.

Quest Diagnostics will offer a Fujirebio blood test this summer to enhance early detection of Alzheimer's disease.

While the current risk to humans of H5N1 remains low, CAP is launching a testing program to help labs better detect and subtype the virus.

AMP has published consensus best practice recommendations to standardize HRD testing in clinical laboratories.

Researchers have developed a handheld TB test that accurately detects tuberculosis in HIV-positive individuals using a single drop of blood.

Juniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.

A new peer-reviewed study validates Vibrant Sciences’ microarray, enabling fast, accurate, scalable detection of over 17 tickborne pathogens.

University of Tokyo researchers have developed a non-invasive, AI-powered imaging system that tracks platelet activity in real time.

Quanterix Corporation's HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration in South Korea.

Two studies demonstrate how AI models can significantly improve early detection of type 1 diabetes, enabling earlier intervention.

A pilot program using Healthy.io’s FDA-cleared smartphone-powered Minuteful Kidney test significantly improved CKD screening and diagnosis.

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis is a life-threatening emergency caused by the body's extreme response to infection, requiring rapid diagnosis and treatment.